About Contact Us Careers
Sign In

Nasogastric Tube Market Size & Share, by Tube (Levin Catheter, Dobhoff Tube, Sengstaken-Blakemore Tube); Patient Group (Adult, Geriatric); Indication (Dysphagia, IBD, Unconsciousness, Neck & Head Cancer, Malnutrition); End-user (Hospitals, Clinics, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5016
  • Published Date: Jun 14, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Nasogastric Tube Market size is expected to surpass USD 1 Billion by the end of 2035, expanding at a CAGR of 6% during the forecast period, i.e., 2023 – 2035. In the year 2022, the industry size of the nasogastric tube was approximately USD 362 Million. The growth of the market will rise owing to a higher count of surgical procedures being carried out. On an annual basis, millions of people get surgical treatment, with surgical treatments accounting for an estimated 13% of total disability-adjusted life years worldwide. During surgery, a nasogastric tube is inserted to remove accumulated air, fluid, or gastrointestinal contents from the stomach.

Furthermore, the number of malnourished people will increase the demand for nasogastric tubes. Nasogastric tubes ensure that essential nutrients, including protein, carbohydrates, fats, vitamins, and minerals are delivered to the body to address malnutrition and promote recovery. In 2021, almost 2.3 billion individuals which is around 29.3% of the global population were either severely or moderately lacked surviving nutrition.

Nasogastric Tube Market
Get more information on this report: Request Free Sample PDF

Nasogastric Tube Market: Growth Drivers and Challenges

Growth Drivers

  • Higher Number of ICU Admissions – The people admitted to ICU, are in severe condition and face difficulties in consuming medicines orally. Nasogastric tubes are used to administer these medicines. In the United States, total non-COVID-19 admissions had risen to 16 percent of pre-pandemic baseline volume by late June/early July 2020.
  • Increasing Prevalence of Chronic Diseases–In certain chronic diseases, such as pancreatic disorders or conditions with excessive fluid accumulation in the abdomen, nasogastric tubes can be used to drain excess fluid or prevent aspiration. By draining fluid from the stomach or preventing its reflux into the lungs, nasogastric tubes can help manage symptoms, reduce the risk of complications, and improve the patient’s life. According to the American Cancer Society's projections for pancreatic cancer in the United States in 2023, around 64,050 persons are anticipated to be diagnosed.
  • Higher Adoption of Enteral Feeding– Nasogastric tubes provide a relatively simple and non-invasive method for enteral feeding in the ICU. They are a temporary solution and are easier to insert. Around 20% of children under the age of 18 are tube fed in America, and there are over 350 conditions that can need children to need nourishment using tube feeding.

    Challenges

  • Infection Caused by the Tube – Nasogastric tubes, being invasive devices, pose a risk of infection. Improper insertion, inadequate maintenance, or prolonged use of the tube can increase the risk of infection, such as bloodstream infections, and pneumonia. Moreover, it can also cause nasal and sinus problems, such as nasal congestion, rhinitis, or sinusitis.
  • Availability and Adoption of Alternative Enteral Access Methods
  • Lack of Reimbursement Policies

Nasogastric Tube Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~ 6%

Base Year Market Size (2022)

~ USD 362 Million

Forecast Year Market Size (2035)

~ USD 1000 Million

Regional Scope
  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Nasogastric Tube Segmentation

Indication (Dysphagia, IBD, Unconsciousness, Neck & Head Cancer, Malnutrition)

The dysphagia segment is estimated to hold over 45% share of the global nasogastric tube market by 2035. Moreover, the segment was responsible for around 21% of the total market portion in 2022. Dysphagia is the weakening and destruction of the nerves and muscles that are required for swelling. The primary cause of dysphagia is stroke, head injury, dementia, and others. Every year, in the world 15 million people are affected by a stroke. 5 million of these people die, and another 5 million are chronically crippled. Due to dysphagia, the risk of malnutrition and dehydration. Nasogastric tubes can provide a means to deliver clinical nutrition directly into the stomach, ensuring the patient is meeting their dietary requirement.

Tube (Levin Catheter, Dobhoff Tube, Sengstaken-Blakemore Tube)

The levin catheter segment in the nasogastric tube market is expected to garner a significant proportion of around 46% in the year 2035. The growth of the segment is credited to the higher adoption of Levin tubes, which has an open tip and only a single lumen. Furthermore, improved access to healthcare services, particularly in developing regions, can contribute to an increased demand for medical procedures that necessitate the use of Levin catheters.

Our in-depth analysis of the global nasogastric tube market includes the following segments:

        Tube
  • Levin Catheter
  • Dobhoff Tube
  • Sengstaken-Blakemore Tube

         Patient Group
  • Adult
  • Geriatric

        Indication
  • Dysphagia
  • IBD
  • Unconsciousness
  • Neck & Head Cancer
  • Malnutrition

         End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
 

 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Nasogastric Tube Market - Regional Synopsis

North American Market Forecast

The nasogastric tube market in North America, will garner the largest share of nearly 39% during the forecast timeframe by rising with significant CAGR over the projected time frame. The development of various supportive regulatory guidelines by the regulatory bodies in the region that creates several investment opportunities for businesses will drive market growth. For instance, in June 2021, the U.S. FDA introduced the guideline for researching and testing oral drug consumption using the enteral feeding tube. Moreover, the growing cases of heart disease and cancer will surge the demand for nasogastric tubes. Since, these diseases require intensive unit care and surgical procedures, therefore the need for enteral feeding rises.

APAC Market Analysis

Asia Pacific nasogastric tube market is anticipated to hold a notable contribution till 2035. The region has a huge population of older adults. Between 2010 and 2050, the region's population of senior people (those over the age of 60) will triple. One in four people will be above 60 years old, reaching a total population of 1.3 billion by 2050. Due to several reasons, such as poor appetite, and medical conditions, older people face trouble in consuming adequate nutrition orally. Nasogastric tubes help in hydration and nutritional management in them.

Research Nester
Nasogastric Tube Market Size
Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Nasogastric Tube Market

top-features-companies
    • Becton, Dickinson and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • QMD
    • Angiplast Pvt. Ltd.
    • Securmed
    • Vygon SAS
    • Medtronic
    • Andersen Products Ltd.
    • Cardinal Health
    • Baihe Medical
    • Poly Medicure Limited

In the News

  • QMD announced the launch of Nasogastric tubes in the portfolio of Degania Enteral Feeding Product. The material used for the manufacturing of these tubes adheres to the standards of ENFit for improving the safety of the patient, the designs are available for both babies and adults.
  • Securmed announced the collaboration with Delta Med Group to expand their company in the Italian and European markets. The agreement will lead to the development of better products of high quality.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5016
  • Published Date: Jun 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of chronic diseases, rising prevalence of malnutrition, higher use of enteral feeding, and higher surgical procedures are the major factors driving the market growth.

The market size of nasogastric tube is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Becton, Dickinson and Company, QMD, Angiplast Pvt. Ltd., Securmed, Vygon SAS, Medtronic, Andersen Products Ltd., Cardinal Health, Baihe Medical, and Poly Medicure Limited.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by tube, patient group, indication, end user, and by region.

The dysphagia segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Cost and reimbursement policies, presence of alternatives, and risk of infections are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Nasogastric Tube Market Report Scope

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying